share_log

Moderna新冠疫苗获得美国FDA紧急使用授权

Moderna Inc COVID-19 Vaccine is authorized for Emergency use of FDA in the United States

新浪财经 ·  Dec 19, 2020 08:44

According to a statement posted on the US Food and Drug Administration (FDA) website on Friday, FDA has approved the Emergency use Authorization (EUA) of Moderna Inc and COVID-19 vaccine, saying that the emergency licensed vaccine is suitable for people aged 18 and above.

Last week, FDA approved Pfizer Inc.This is the second experimental vaccine to be urgently licensed in the United States after the vaccine from its partner BioNTech SE.

Moderna Inc's vaccine uses new m-RNA technology similar to Pfizer Inc Biotechnology, and the effectiveness of preventing COVID-19 's symptoms is 94.1%, FDA staff said in a report on Tuesday.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment